| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VALERITAS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 244,30 | +0,25 % | Dividendenbekanntmachungen (09.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANSIX INC US00773T1016 0,16 USD 0,1377 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,29 USD 0,2496 EUR ALPHABET INC CDR CA02080K1049 0... ► Artikel lesen | |
| THERMO FISHER | 439,25 | -0,03 % | Thermo Fisher Opens Bay Area Cryo-EM Drug Discovery Center | ||
| TELADOC HEALTH | 4,964 | +8,36 % | BofA raises Teladoc stock price target on virtual therapy M&A | ||
| ROKU | 85,57 | -0,60 % | Is Roku Stock a Buy as Platform Revenues and ARPU Improve? | ||
| RESMED | 217,50 | -0,18 % | Resmed, Inc.: Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach | Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains
53% of people surveyed rank sleep as the most important behavior for a long... ► Artikel lesen | |
| HENRY SCHEIN | 65,90 | -2,05 % | Leerink Partners bestätigt Rating für Henry Schein bei Kursziel von 87 $ | ||
| ZIMMER BIOMET | 79,02 | -1,67 % | Zimmer Biomet Holdings, Inc.: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 | WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board... ► Artikel lesen | |
| PETMED EXPRESS | 2,159 | -3,44 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results | Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for... ► Artikel lesen | |
| TANDEM DIABETES | 17,670 | -2,56 % | Tandem Diabetes care launches Mobi pump on Android phones | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| QUIDELORTHO | 16,900 | -1,17 % | QuidelOrtho präsentiert Wachstumsstrategie auf Raymond James Konferenz | ||
| QUEST DIAGNOSTICS | 173,05 | +0,06 % | Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer | Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a... ► Artikel lesen | |
| VERU | 2,490 | 0,00 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| SENSEONICS | 5,400 | +1,89 % | Stifel reiterates Hold on Senseonics stock, cites cash burn concerns |